Optimal therapy for Helicobacter pylori infections (Q37835707)

24 August 2017

1 reference

title

Optimal therapy for Helicobacter pylori infections (English)

1 reference

Helicobacter pylori infectious disease

24 August 2017

0 references

1 reference

3

David Y Graham

1 reference

24 August 2017

Emiko Rimbara

1

1 reference

PubMed ID

21293508

24 August 2017

Lori A Fischbach

series ordinal

2

1 reference

PubMed ID

21293508

24 August 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

Nature Reviews Gastroenterology & Hepatology

24 August 2017

1 reference

24 August 2017

8

1 reference

24 August 2017

79-88

1 reference

24 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2010.210

24 August 2017

0 references

cites work

Helicobacter pylori infection: a clinical overview

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Pathogenesis and therapy of gastric and duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Antibiotic resistance in Helicobacter pylori: implications for therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

New concepts of resistance in the treatment of Helicobacter pylori infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

H pylori antibiotic resistance: prevalence, importance, and advances in testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Helicobacter pylori and antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

How to achieve a near 100% cure rate for H. pylori infection in peptic ulcer patients. A personal viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Helicobacter pylori treatment in the era of increasing antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Practical rapid, minimally invasive, reliable nonendoscopic method to obtain Helicobacter pylori for culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Distribution of gyrA mutations in fluoroquinolone-resistant Helicobacter pylori strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Mutations in Helicobacter pylori rdxA gene sequences may not contribute to metronidazole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Characterization of the genes rdxA and frxA involved in metronidazole resistance in Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Multiple mutations in or adjacent to the conserved penicillin-binding protein motifs of the penicillin-binding protein 1A confer amoxicillin resistance to Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Stool polymerase chain reaction for Helicobacter pylori detection and clarithromycin susceptibility testing in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Evaluation of the novel Helicobacter pylori ClariRes real-time PCR assay for detection and clarithromycin susceptibility testing of H. pylori in stool specimens from symptomatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Fast and Accurate Quantitative Detection of Helicobacter pylori and Identification of Clarithromycin Resistance Mutations in H . pylori Isolates from Gastric Biopsy Specimens by Real-Time PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Modified allele-specific primer-polymerase chain reaction method for analysis of susceptibility of Helicobacter pylori strains to clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Rapid detection of point mutations conferring resistance to fluoroquinolone in gyrA of Helicobacter pylori by allele-specific PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Detection of Helicobacter pylori and determination of clarithromycin susceptibility using formalin-fixed, paraffin-embedded gastric biopsy specimens by fluorescence in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Detection of clarithromycin-resistant Helicobacter pylori in frozen gastric biopsies from pediatric patients by a commercially available fluorescent in situ hybridization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Detection of Helicobacter pylori in paraffin-embedded and in shock-frozen gastric biopsy samples by fluorescent in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Helicobacter in the developing world

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Projections of global mortality and burden of disease from 2002 to 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

What is the Helicobacter pylori global reinfection rate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Helicobacter pylori reinfection in Brazilian patients with peptic ulcer disease: a 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Long-term re-infection rate after Helicobacter pylori eradication in Bangladeshi adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Long term follow up of patients treated for Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Long-term recurrence rate after treatment of Helicobacter pylori infection in children and adolescents in Estonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Helicobacter pylori reinfection rate 3 years after successful eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Eradication of Helicobacter pylori infection in patients with duodenal ulcer and non-ulcer dyspepsia and analysis of one-year reinfection rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Oral cavity as a potential source of gastric reinfection by Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Persistence of Helicobacter pylori infection in patients with peptic ulcer perforation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Recurrence of Helicobacter pylori infection 1 year after successful treatment: prospective cohort study in the Republic of Yemen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

After the eradication of Helicobacter pylori infection, relapse is a serious problem in Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Helicobacter pylori recurrence in patients with duodenal ulcer: Clinical, endoscopic, histologic, and genotypic aspects. A 10-year Brazilian series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Dietary and socio-economic factors in relation to Helicobacter pylori re-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Detection of mixed clarithromycin-resistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Determination of mutations of the 23S rRNA gene of Helicobacter pylori by allele specific primer-polymerase chain reaction method

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

High recurrence rate of Helicobacter pylori infection in developing countries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

A report card to grade Helicobacter pylori therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Low reinfection rate of Helicobacter pylori infection in Turkey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Distribution of vacA genotypes in Helicobacter pylori strains isolated from Brazilian adult patients with gastritis, duodenal ulcer or gastric carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Epidermal growth factor and transforming growth factor alpha in duodenal ulcer and non-ulcer dyspepsia patients before and after Helicobacter pylori eradication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2010.210

Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay

31 March 2020

1 reference

12 December 2020

Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?

1 reference

12 December 2020

Reinfection Rate after Successful Helicobacter pylori Eradication in Children

1 reference

12 December 2020

Helicobacter pylori, a causative agent of vitamin B12 deficiency

1 reference

12 December 2020

Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations

1 reference

12 December 2020

Sequential therapy for Helicobacter pylori eradication: a critical review

1 reference

12 December 2020

[Comparison of 2 treatment schemes to eradicate Helicobacter pylori]

1 reference

12 December 2020

Does the eradication of Helicobacter pylori cure duodenal ulcer disease in communities with a high prevalence rate? Comparison with long-term acid suppression

1 reference

12 December 2020

Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patien

1 reference

12 December 2020

Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication

1 reference

12 December 2020

A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.

1 reference

12 December 2020

Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance.

1 reference

12 December 2020

Helicobacter pylori eradication therapy research: Ethical issues and description of results

1 reference

12 December 2020

Helicobacter pylori reinfection after apparent eradication--the Ipswich experience.

1 reference

12 December 2020

PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates

1 reference

12 December 2020

Novel method for rapid determination of clarithromycin sensitivity in Helicobacter pylori

1 reference

12 December 2020

Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients

1 reference

12 December 2020

Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase

1 reference

12 December 2020

Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation)

1 reference

12 December 2020

Natural history of severe duodenal ulcer disease

1 reference

12 December 2020

Acquisition of Helicobacter pylori infection and reinfection after its eradication are uncommon in Indian adults

1 reference

12 December 2020

Recurrence of Helicobacter pylori infection 1 year after successful eradication: a prospective study in Northern Iran

1 reference

12 December 2020

Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study

1 reference

12 December 2020

Randomized trial of a quadruple-drug regimen and a triple-drug regimen for eradication of Helicobacter pylori: long-term follow-up study.

1 reference

12 December 2020

A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori

1 reference

12 December 2020

10.1038/NRGASTRO.2010.210

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21293508